Company · CIK 0001817241 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Artiva Biotherapeutics, Inc. · ARTV
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 15, 4:44 pm EDT | Fred AslanChief Executive Officer, Director | 110,000 | — | — | 1,604,765 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 8:07 pm EDT | Fred AslanChief Executive Officer, Director | 45,000 | — | — | 1,494,765 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:37 pm EDT | Gines Diego MirallesPresident & Head of R&D | 45,000 | — | — | 122,500 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:36 pm EDT | Christopher HoranChief Tech Operations Officer | 40,000 | — | — | 323,084 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:36 pm EDT | Jennifer BushCOO, CLO, Compliance Officer | 45,000 | — | — | 374,529 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:35 pm EDT | Subhashis BanerjeeChief Medical Officer | 30,000 | — | — | 170,947 | — | |
| Sep 8, 2026 SForm 4 → | Sep 9, 4:02 pm EDT | Fred AslanChief Executive Officer, Director | 23,429 | $10.92 | $255,746 | 1,449,765 | −1.59% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:04 pm EDT | Christopher HoranChief Tech Operations Officer | 10,366 | $11.16 | $115,638 | 283,084 | −3.53% | |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:03 pm EDT | Jennifer BushCOO, CLO, Compliance Officer | 8,391 | $11.16 | $93,606 | 329,529 | −2.48% | |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:03 pm EDT | Subhashis BanerjeeChief Medical Officer | 1,100 | $11.16 | $12,271 | 140,947 | −0.77% | |
| Sep 3, 2026 SForm 4 → | Sep 4, 4:02 pm EDT | Fred AslanChief Executive Officer, Director | 61,888 | $11.16 | $690,392 | 1,473,194 | −4.03% | |
| Aug 27, 2026 SForm 4 → | Aug 31, 7:06 pm EDT | Subhashis BanerjeeChief Medical Officer | 8,222 | $12.01 | $98,736 | 142,047 | −5.47% | 10b5-1 |
| Aug 27, 2026 MForm 4 → | Aug 31, 7:06 pm EDT | Subhashis BanerjeeChief Medical Officer | 5,306 | $1.92 | $10,188 | 150,269 | — | 10b5-1 |
| Aug 18, 2026 SForm 4 → | Aug 19, 9:00 pm EDT | Subhashis BanerjeeChief Medical Officer | 429 | $12.00 | $5,148 | 144,963 | −0.30% | 10b5-1 |
| Aug 18, 2026 MForm 4 → | Aug 19, 9:00 pm EDT | Subhashis BanerjeeChief Medical Officer | 429 | $1.92 | $824 | 145,392 | — | 10b5-1 |
| Jul 29, 2026 PForm 4 → | Jul 31, 5:13 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 45,768 | $9.96 | $455,726 | 17,329,570 | +0.26% | |
| Jul 24, 2026 PForm 4 → | Jul 28, 5:24 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 41,319 | $9.99 | $412,777 | 17,283,802 | +0.24% | |
| Jul 21, 2026 PForm 4 → | Jul 23, 9:22 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 264,586 | $9.76 | $2,583,314 | 17,242,483 | +1.56% | |
| Jul 16, 2026 PForm 4 → | Jul 20, 6:08 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 160,354 | $8.93 | $1,432,119 | 16,977,927 | +0.95% | |
| Jul 13, 2026 PForm 4/A → | Jul 23, 9:21 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 6,522 | $8.94 | $58,307 | 16,817,543 | +0.04% | |
| Jul 10, 2026 PForm 4 → | Jul 14, 7:00 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 21,654 | $8.96 | $194,040 | 16,817,573 | +0.13% |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 AForm 4 → | Sep 15, 4:44 pm EDT | Fred AslanChief Executive Officer, Director | 315,000 | — | — | 315,000 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 8:07 pm EDT | Fred AslanChief Executive Officer, Director | 155,000 | — | — | 155,000 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 6:46 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:05 pm EDT | Laura StoppelDirector | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:04 pm EDT | Elaine K. SorgDirector | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:04 pm EDT | Elizabeth L HougenDirector | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:03 pm EDT | Brian DanielsDirector | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:03 pm EDT | Daniel G. BakerDirector | 16,250 | — | — | 16,250 | — | |
| Sep 10, 2026 AForm 4 → | Sep 14, 4:02 pm EDT | Alison MooreDirector | 16,250 | — | — | 16,250 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:37 pm EDT | Gines Diego MirallesPresident & Head of R&D | 135,000 | — | — | 135,000 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:36 pm EDT | Christopher HoranChief Tech Operations Officer | 120,000 | — | — | 120,000 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:36 pm EDT | Jennifer BushCOO, CLO, Compliance Officer | 135,000 | — | — | 135,000 | — | |
| Sep 9, 2026 AForm 4 → | Sep 11, 6:35 pm EDT | Subhashis BanerjeeChief Medical Officer | 85,000 | — | — | 85,000 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 6:29 pm EDT | RA CAPITAL MANAGEMENT, L.P. +5Director, 10% Owner | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:58 pm EDT | Laura StoppelDirector | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:57 pm EDT | Elaine K. SorgDirector | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:56 pm EDT | Elizabeth L HougenDirector | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:56 pm EDT | Brian DanielsDirector | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:55 pm EDT | Daniel G. BakerDirector | 13,750 | — | — | 13,750 | — | |
| Sep 8, 2026 AForm 4 → | Sep 8, 5:55 pm EDT | Alison MooreDirector | 13,750 | — | — | 13,750 | — | |
| Aug 27, 2026 MForm 4 → | Aug 31, 7:06 pm EDT | Subhashis BanerjeeChief Medical Officer | 5,306 | — | — | 74,265 | — | 10b5-1 |
| Aug 18, 2026 MForm 4 → | Aug 19, 9:00 pm EDT | Subhashis BanerjeeChief Medical Officer | 429 | — | — | 79,571 | — | 10b5-1 |